| # | Drug | Count |
|---|---|---|
| 0 | ENCORAFENIB | 3 |
| 1 | ACETAMINOPHEN | 2 |
| 2 | ACETAMINOPHEN, GUAIFENESIN, AND PHENYLEPHRINE HYDROCHLORIDE | 2 |
| 3 | ADALIMUMAB | 2 |
| 4 | LEVOTHYROXINE SODIUM | 2 |
| 5 | LEVOTHYROXINE SODIUM ANHYDROUS | 2 |
| 6 | ADALIMUMAB-AATY | 1 |
| 7 | ADALIMUMAB-ADAZ | 1 |
| 8 | ADALIMUMAB-FKJP | 1 |
| 9 | AMIVANTAMAB-VMJW | 1 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | ENCORAFENIB | 3 | 0.0003 |
| 1 | AMIVANTAMAB-VMJW | 1 | 0.0003 |
| 2 | RITUXIMAB-ABBS | 1 | 0.0002 |
| 3 | BINIMETINIB | 1 | 0.0001 |
| 4 | PROCHLORPERAZINE MALEATE | 1 | 0.0001 |
| 5 | LOPERAMIDE HCL | 1 | 0.0001 |
| 6 | IRINOTECAN HYDROCHLORIDE | 1 | 0.0001 |
| 7 | LEUCOVORIN CALCIUM | 1 | 0.0001 |
| 8 | SOFOSBUVIR | 1 | 0.0001 |
| 9 | ASCORBIC ACID | 1 | 0.0000 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Hepatitis C Virus Nucleotide Analog NS5B Polymerase Inhibitor [EPC] | 1 | 0.0000 |
| 1 | Expectorant [EPC] | 2 | 0.0000 |
| 2 | Sodium-Glucose Cotransporter 2 Inhibitor [EPC] | 1 | 0.0000 |
| 3 | Serotonin-3 Receptor Antagonist [EPC] | 1 | 0.0000 |
| 4 | Calcium [EPC] | 1 | 0.0000 |
| 5 | RANK Ligand Inhibitor [EPC] | 1 | 0.0000 |
| 6 | Folate Analog Metabolic Inhibitor [EPC] | 2 | 0.0000 |
| 7 | Opioid Agonist [EPC] | 1 | 0.0000 |
| 8 | Platinum-based Drug [EPC] | 1 | 0.0000 |
| 9 | Nucleoside Metabolic Inhibitor [EPC] | 1 | 0.0000 |